Carrier Screening Market Research Report: By Type (Expanded Carrier Screening, Targeted Carrier Screening), Application (Cystic Fibrosis, Thalassemia, Spinal Muscular Atrophy, Sickle Cell Disease, Fragile X Syndrome), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarray), End User (Hospitals, Laboratories, Clinics)
NEW YORK, May 14, 2020 (GLOBE NEWSWIRE) -- To check the high prevalence of genetic disorders, biotechnological companies are introducing a number of cost-effective and technologically advanced testing kits and products. For instance, in October 2019, Sema4 (Mount Sinai Genomics Inc.) expanded its carrier screen with personalized residual risk, to offer healthcare providers and patients a better assessment of the genetic disease risk.
As a result of the testing kits becoming more advanced and cost-effective, the global carrier screening market, which reached $1,303.6 million in 2019, is predicted to grow at a 10.9% CAGR between 2020 and 2030. This is because of the increasing efficiency and reducing costs of the tests, which is driving the demand for them, among people planning a family.
Get the Sample Copy of this Report at: https://www.psmarketresearch.com/market-analysis/carrier-screening-market/report-sample
Expanded Carrier Screening To Be Larger Type in Carrier Screening Market
The expanded carrier screening bifurcation is projected to continue holding larger share in the carrier screening market till 2030. This is attributed to the fact that with this approach, a number of genetic diseases can be tested for at once. Another reason behind the dominance of this bifurcation on the industry is the heavy usage of the next-generation sequencing (NGS) technique for genetic disease screening.
In 2019, the deoxyribonucleic acid (DNA) sequencing division contributed the highest revenue to the carrier screening market, on account of the integration of user-friendly tools with the technology and its declining prices. Moreover, this technology is more accessible, as the people using it for testing do not need to be bioinformatics experts.
Browse report overview with 123 tables and 56 figures spread through 160 pages and detailed TOC on “Carrier Screening Market: Industry Size, Share, Growth and Forecast to 2030" at: https://www.psmarketresearch.com/market-analysis/carrier-screening-market
During the forecast period, the cystic fibrosis classification would witness the highest CAGR in the carrier screening market, due to the increasing number of people being diagnosed with this genetic condition in North America and Europe. In addition, the awareness about the advantages of diagnosing the disease early is rising, thereby driving the test volume.
North America was the highest-revenue-generating carrier screening market during the historical period (2014–2019), as a result of the growing number of tests being done to determine whether a person is carrying the gene for an inherited disease. Moreover, several established market players are present in the region, which also has the most advanced healthcare infrastructure in the world. In the coming years, the fastest market growth is expected in Asia-Pacific (APAC), as people in Australia, China, and India are becoming rapidly knowledgeable about genetic diseases and screening tests. Additionally, APAC is the most populated region on earth, and the prevalence of genetic diseases is rising here, particularly in China and India.
Make Enquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=carrier-screening-market
Market Players Entering into Partnerships to Increase their Presence
A number of partnerships are being initiated in the carrier screening market, with the companies, offering these solutions, looking to:
- Leverage each other’s platforms for their products
- Combine each other’s technology, to offer improved solutions
- Commercialize their products outside their home country
- Widen their customer base
- Advance their technology with each other’s expertise
The most prominent companies operating in the global carrier screening market include Invitae Corporation, Illumina Inc., Thermo Fisher Scientific Inc., Otogenetics Corporation, Myriad Genetics Inc., Luminex Corporation, Gene By Gene Ltd., MedGenome Inc., Natera Inc., Laboratory Corporation of America Holdings, and Mount Sinai Genomics Inc.
More Reports of Life Sciences by P&S Intelligence
Blood Screening Market
The stringent regulations aimed at checking blood contamination, rising number of blood donors, surging incidence of chronic, infectious, and respiratory diseases, technological advancements, and escalating healthcare expenditure are the key reasons behind the rapid adoption of the blood screening process. These factors are expected to together drive the global blood screening market, which generated $2,402.3 million in 2019, at an 8.1% CAGR during 2020–2030 (forecast period).
https://www.psmarketresearch.com/market-analysis/blood-screening-market
Cell Isolation Market
North America and Europe accounted for 68.8% of the global cell isolation market size in 2017. This is due to the existence of a significant number of research institutions, academic institutes, pharmaceutical and biotechnology firms, as well as hospitals and testing laboratories, performing extensive research using cell isolation methods and consumables.
http://www.psmarketresearch.com/market-analysis/cell-isolation-market
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com